RGT 2.94% 33.0¢ argent biopharma limited

Ann: Phase II Clinical Trial on Patients Diagnosed with COVID-19, page-13

  1. 17 Posts.
    lightbulb Created with Sketch. 29
    Im a holder too and sometimes agree with your sentiments. But imo this is nothing to get too excited over, we could be waiting 6 months for more money to be spent on non-core business operations, with the possibility of the results coming back negative - which would further harm the value of the JV deal. Taking it with a grain of salt at the moment....
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
-0.010(2.94%)
Mkt cap ! $15.97M
Open High Low Value Volume
34.5¢ 36.5¢ 32.5¢ $8.486K 24.25K

Buyers (Bids)

No. Vol. Price($)
1 3000 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 3333 1
View Market Depth
Last trade - 15.46pm 03/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.